Up to 180kW for Solar String Inverters – MiniSKiiP Dual Split MLI

SEMIKRON offers a broad portfolio of 3-level modules, the latest addition being the MiniSKiiP Dual Split MLI. The new module increases the nominal current to 400A in 1200V and 950V devices and comes with the option of SiC Schottky diodes in the neutral path for maximum efficiency. This new module allows for baseplate-less, PCB-mounted inverter designs with benchmarking power density of up to 180kW for 1500VDC photovoltaic systems. The benefits of the MiniSKiiP Dual’s SPRiNG contact layout are low-inductance DC-link designs, easy driver integration and parallel AC power connections.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

WKR Walter Austria: Start-up of another Herbold film wash line

To extend its facility in Wels, Austria, WKR Walter has chosen a complete integrated solution from HERBOLD Meckesheim GmbH, based in Meckesheim/Germany. The key component of the plant is the latest generation of HERBOLD’s VWE pre-wash system, hydrocyclone separation and a twin centrifugal drying step. WKR Walter recycles post consumer film.

The infeed of the line is baled material, sourced from Germany, based on DSD 310 spec. It provides for the efficient cleaning of the material a hydrocyclone separation step as a key requirement for the production of high-grade recyclate for manufacturing of thin-walled film . HERBOLD and WKRWalter are looking back to a long-term cooperation. All the three existing wash lines have been upgraded by HERBOLD Meckesheim GmbH with hydrocyclones in the last couple of years, having allowed WKRWalter to upgrade the quality of the washed flakes to a new level. For the first time WKRWalter is able to operate a film wash line without the need of a thermal drying unit, thanks to the efficient operation of the HERBOLD centrifuge.

The new line is designed for 10.000 t/year, WKR Walter is already discussing a further expansion.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

RavenQuest completes first cannabis shipment to Wayland Group

RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest” – https://www.commodity-tv.net/c/search_adv/?v=298814 ) a federally licensed producer of cannabis, is pleased to announce it has completed its first shipment of bulk cannabis to Wayland Group.

The shipment was made as part of a larger agreement between RavenQuest and Wayland group, whereby RavenQuest will supply up to 8,000 kg of bulk cannabis to Wayland Group. The agreement spans the entirety of calendar 2019.

CEO, George Robinson commented that “it has been a pleasure dealing with Ben Ward and the entire team at Wayland Group. We are very excited to complete this first shipment, which represents the beginning of our agreement as we fulfill our commitment to supply premium cannabis to our partners at Wayland.”

“The new license at our Edmonton facility brings significantly more capacity onstream, dramatically increasing our revenue potential for 2019. In addition to this agreement, we have also signed an MOU to supply cannabis to the British Columbia Liquor Distribution Branch. Between these two distribution channels and based upon prevailing B2B market prices, we’re confident we can ramp up revenue to north of the budgeted $44.5 million for 2019.” Robinson continued.

For more information, view RavenQuest’s updated website at www.rqbglobal.com.

Follow RavenQuest on Twitter @RQBGlobal

About RavenQuest BioMed Inc.

RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development. RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta.

RavenQuest maintains a research partnership with McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant. The Company focuses on partnerships with Indigenous communities.

On Behalf of the Board of Directors of AVENQUEST BIOMED INC.

"George Robinson" Chief Executive Officer

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statements

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including statements with respect to anticipated production capacity. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited to those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

Readers are cautioned that budgeted revenue is based upon prevailing prices for the supply of cannabis products in business-to-business transactions, and assumes annual production of 11,000 kilograms of cannabis from the Company’s Edmonton facility. A number of factors may cause actual results to differ materially from budgeted amounts, including changes in the market price and demand for cannabis products, interruptions in production and operations at the Company’s facility and an evolving government and regulatory landscape.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

Greatly optimised platform: Latest release from oneclick™ now available

The intensive development work of recent months has paid off. This is the consistent opinion of the partners, who have already tested the latest release of the Workspace Provisioning and Streaming Platform. The functionalities, operability and application possibilities are "completely renewed, improved and embellished", according to systems integrators that provide their customers with individualised digital workspaces via the web-based oneclick™ platform.

One example is the new administration area, which is now much more convenient to use. User-defined access policies can be added more easily and groups can be created more flexibly than before to "facilitate user and application management in complex organizations," explains Florian Bodner, CIO of oneclick AG.

The renewed Cloud Resource Manager also features increased functionality: In addition to the automated creation of new cloud resources on IaaS platforms, systems integrators (or their customers) now also have the option of reading out existing resources, managing them within the oneclick™ platform – and assigning them to the workspaces of the desired users.

Process Automation and Design Flexibility

On the cost side, improvements have also been reported: Adjustable event profiles for the start and stop of resources optimize consumption; in addition, the Cloud Resource Manager now also displays the prices of available virtual machines.

The new Single Sign-On, which can integrate external SSO providers and enables login via Azure AD or other third-party tools, provides greater user convenience and increased security. Users can log in to oneclick™ with their existing password (e.g. that for Office 365) and gain access to all stored applications for which no further login process is necessary, as authentication takes place automatically.

Another major innovation is that users can open several apps with oneclick™ in their own browser tabs and thus – even in multi-monitor operation – work with them. The optimised streaming protocol ensures significantly shorter loading times.

In order to strengthen the loyalty of employees to their company, oneclick can replace the logo and the entire background of the workspaces with a desired customer design on request. This white labelling offers customers the highest level of customisation of their workspaces.

However, the new version of oneclick™ also offers significant added value for software vendors. The automated ordering and provisioning process for third-party software (such as Sage), including price calculation, should be mentioned here above all. For software vendors, oneclick™ can map all license models, access restrictions, etc. and also has an API that can communicate with third-party systems.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

Feasibility Study & Project Finance Updates

Cardinal Resources Limited (ASX/TSX: CDV – http://www.commodity-tv.net/c/search_adv/?v=298772) is pleased to announce an update to our Feasibility Study (“FS”) and Project Finance (“PF”) activities in respect of the Company’s Ore Reserve at the Namdini Gold Project in Ghana (ASX/TSX release dated 3 April 2019).

  • The Namdini Gold Project Feasibility Study is progressing rapidly and is now expected to be delivered this quarter, one quarter ahead of schedule
  • Cardinal’s Project Finance Advisor, Cutfield Freeman (London), is assessing term sheets for project finance which have been received from banks and other project financiers
    • Strong interest shown from a number and variety of different potential project financiers
    • Independent Experts appointed to minimise delays with due diligence

Cardinal’s Chief Executive Officer / Managing Director, Archie Koimtsidis stated:

“The entire Feasibility Study team has been performing an exceptional job of bringing together the Feasibility Study for Cardinal’s Namdini Gold Project well ahead of its original planned completion of Q3 CY2019.

“Finalisation of the Feasibility Study within this quarter will be a significant step forward for the Company as it continues to substantiate the significant value inherent in the Namdini Gold Project for investors.

“The Pre-Feasibility Study has already demonstrated the robust nature of our Namdini Gold Project, and provides a strong body of work which has been leveraged off for the Feasibility Study. The Feasibility Study will factor an optimisation study that has recently been undertaken on the Namdini Gold Ore Reserve, to ensure the optimal Stage 1 pit design to accelerate capital payback and maximise returns for shareholders.

“Study Manager Lycopodium, continues to accelerate the full integration of all project disciplines and to coordinate the efforts of our other study partners including Golder Associates and Knight Piésold.

“Lycopodium are a highly respected mining services company that has over 25 years’ Global experience in the minerals industry, designing and building large-scale mines, processing plants and associated infrastructure, particularly in Africa and West Africa.”

Project Finance Update

Project Finance Advisers, Cutfield Freeman, have been working closely with Cardinal to ensure that Cardinal is well positioned to execute project finance for the Namdini Gold Project as swiftly as possible following completion of the Feasibility Study.

There has been very strong interest received from a range of potential financiers, providing the Company with a strong degree of confidence that it will be capable of securing the required project funding package on favourable terms.

Cardinal’s Project Finance team is continuing to evaluate Indicative Term Sheets from a number of project financiers – traditional senior debt lenders to possible corporate scenarios.

ABOUT CARDINAL
Cardinal Resources Limited (ASX/TSX: CDV) is a West African gold‐focused exploration and development Company that holds interests in tenements within Ghana, West Africa.

The Company is focused on the development of the Namdini Project with a gold Ore Reserve of 5.1Moz (0.2 Moz Proved and 4.9 Moz Probable) and a soon to be completed Feasibility Study.

Exploration programmes are also underway at the Company’s Bolgatanga (Northern Ghana) and Subranum (Southern Ghana) Projects.

Cardinal confirms that it is not aware of any new information or data that materially affects the information included in its announcement of the Ore Reserve of 3 April 2019. All material assumptions and technical parameters underpinning this estimate continue to apply and have not materially changed.

Please follow the link to view entire original news in English:
https://www.asx.com.au/asxpdf/20190410/pdf/4446bwpzhdl36m.pdf

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

RavenQuest Provides Update on Recent License and Production Capacity Expansion

RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest” – https://www.commodity-tv.net/c/search_adv/?v=298814 ) a federally licensed producer of cannabis, is pleased to provide an update following receipt of its cultivation license at its Edmonton facility and the capacity expansion that comes with it.

Licensing of the Edmonton facility represents an inflection point for the Company, increasing its licensed annual cannabis production capacity to 11,000 kg—a 275% increase.

RavenQuest currently has a supply agreement with Wayland Group, whereby RavenQuest has agreed to supply them with up to 8,000 kg of cannabis in 2019.  RavenQuest has also entered a memorandum of understanding with the British Columbia Liquor Distribution Branch (“BCLDB”) and expects to enter into an agreement in to sell the remainder of its cannabis production to them in 2019.

With respect to ramping up production at the newly licensed Edmonton facility, RavenQuest CEO, George Robinson stated “we have an experienced team in place at both Edmonton and Markham facilities to ensure starting material is expedited safely from the Markham facility to the Edmonton facility.  Our experience in cannabis consulting, together with the seasoned plant expertise of Dr. Simerjeet Kaur and her team will enable us to bring production online in Edmonton properly and at a rapid pace”.

“With the Edmonton facility online, RavenQuest is on track to fulfill its supply agreement with the Wayland Group and expects to be in a position to supply the BCLDB with cannabis once a definitive supply agreement is reached” Robinson continued.

In addition to an increase in cannabis revenue for 2019, RavenQuest also anticipates a record year for its Services Division, with several new clients signing contracts including, notably, a one year agreement with Bonify valued at $1.5 million.

Once legalized, RavenQuest intends to deliver on its broader growth strategy to provide value-added products across a wide spectrum of delivery options including vaporization, edibles and beverages.  “Our plans include a diversified product offering of unique experiences for cannabis consumers.  These products will differ substantially from the fractional distillates planned by our competitors.  Instead, we will place the emphasis on the full plant extract, with the myriad flavours and profiles that come with passing through the full plant experience to value added products” stated Robinson.

“As we move past the licensing phase,” stated Robinson, “2019 promises to be an unprecedented year for RavenQuest and our stakeholders.  We are excited to take the Company from the buildout phase to the revenue and profitability phase, and continuing to accelerate our growth trajectory.  There is much to look forward to for RavenQuest BioMed in 2019.”

For more information, view RavenQuest’s updated website at www.rqbglobal.com.

The BCLDB is responsible for regulating private retail cannabis licensing and the distribution of cannabis to retail stores in British Columbia’s legal adult-use recreational cannabis marketplace. The MOU does not represent a binding purchase agreement, and any distribution of cannabis products to the BCLDB is subject to the negotiation of such an agreement on the terms specified by the BCLDB. The Company will provide additional information regarding the BCLDB supply and distribution process as it becomes available.

Follow RavenQuest on Twitter @RQBGlobal

About RavenQuest BioMed Inc.

RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.  RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta.

RavenQuest maintains a research partnership with McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant.  The Company focuses on partnerships with Indigenous communities.

On Behalf of the Board of Directors of
RAVENQUEST BIOMED INC.

"George Robinson"
Chief Executive Officer

For further information, please contact: Mathieu McDonald, Corporate Communications
1-877-282-1586

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statements

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including statements with respect to anticipated production capacity.  The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes.  By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved.  These risks and uncertainties include but are not limited to those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements.  The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

EnWave Signs Commercial License Agreement with Fresh Business Consulting and Receives Purchase Order for REVTM Machinery

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company" – http://www.commodity-tv.net/c/search_adv/?v=298830 ) reported today that it has signed a royalty-bearing commercial license agreement (the “Agreement”) with Fresh Business Consulting S.L. (“Fresh Business”). Fresh Business is part of a diversified investment and consulting firm that has business interests in Spain (headquarters), the United Kingdom and Peru. Fresh Business also submitted a purchase order for a small-scale commercial Radiant Energy Vacuum (“REV™”) machine to initiate commercial production in Peru.

The Agreement grants Fresh Business the exclusive rights to produce a variety of premium food products in Peru. By processing in Peru, Fresh Business is well positioned to take advantage of the diverse, locally grown agricultural products while utilizing EnWave’s proprietary REV™” technology to create value-added products for export into western markets. REV™ technology is a proven method to create healthy, premium fruit and vegetable products that can be sold as ingredients or as retail consumer products. This Agreement further validates the value proposition for EnWave’s technology to drive innovation in the global fruit and vegetable market vertical.

Fresh Business must commit to purchasing a second EnWave machine of 100kW or greater in rated power before July 31, 2019 in order to retain its exclusivity under the Agreement. Fresh Business and EnWave have also agreed to a coordinated joint effort to secure additional commercial licenses for EnWave’s technology in Peru. The other terms of the Agreement remain confidential.

About Fresh Business Consulting S.L.

Fresh Business employs a business model where professionals with an advanced vision in the integration of creativity, marketing and innovation apply their know-how to improve their clients’ business strategy. Fresh Business is committed to uniquely generating new business ideas that are competitive in today’s marketplace.

Fresh Business’ positive and proactive attitude, their desire to excel and the constant search for new challenges, led them to expand their business, developing a new division, Fresh Business Food & Nutrition Innovation,  focused on the agri-food industry. Fresh Business Food & Nutrition Innovation,  has its own approach to connect creativity, knowledge, technology and marketing to create, incubate and develop innovative food businesses with an international vocation. 

For more information about Fresh Business Consulting S.L. please visit www.freshgroup.es and www.freshbusiness.es

About EnWave

EnWave Corporation, a Vancouver-based advanced technology company, has developed Radiant Energy Vacuum (“REV™”) – an innovative, proprietary method for the precise dehydration of organic materials. EnWave has further developed patent-pending methods for uniformly drying and decontaminating cannabis through the use of REV™ technology, shortening the time from harvest to marketable cannabis products. 

REV™ technology’s commercial viability has been demonstrated and is growing rapidly across several market verticals in the food, and pharmaceutical sectors including legal cannabis. EnWave’s strategy is to sign royalty-bearing commercial licenses with industry leaders in multiple verticals for the use of REV™ technology. The company has signed over twenty royalty-bearing licenses to date, opening up nine distinct market sectors for commercialization of new and innovative products. In addition to these licenses, EnWave has formed a Limited Liability Corporation, NutraDried Food Company, LLC, to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese® brand. 

EnWave has introduced REV™ as the new dehydration standard in the food and biological material sectors: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently has three commercial REV™ platforms:

  1. nutraREV® which is used in the food industry to dry food products quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour;
  2. powderREV® which is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point, and
  3. quantaREV® which is used for continuous, high-volume low-temperature drying.

An additional platform, freezeREV®, is being developed as a new method to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Mr. Brent Charleton, CFA
President and CEO

For further information:

Brent Charleton, CFA , President and CEO at +1 (778) 378-9616
E-mail: bcharleton@enwave.net      

John P.A. Budreski, Executive Chairman at +1 (416) 930-0914
E-mail: jbudreski@enwave.net  

Deborah Honig, Corporate Development at + 1 (647) 203-8793
E-mail: dhonig@enwave.net

In Europe
Swiss Resource Capital AG
Jochen Staiger
info@resource-capital.ch
www.resource-capital.ch

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

Innovative „Train Ring“ is the best rail train solution – Switch Cars, No Reconfiguration

Reduce Cost with High Customer Satisfaction

During current train operation, train cars might need to be separated and reoriented due to more flexible operating requirement. Take MRT for example, it needs more cars during peak hours while only few cars are needed during offpeak hours. A longdistance train route may separate into two shorter trains and heading to different destinations at a junction point. When a train system has higher flexibility, it can utilize the resource and reduces operational costs.

When train cars are switched, reconfigure network settings is normally required. Thus, railway operators need to have enough knowledge of Ethernet. This not only increases the cost of labor but also result in additional time. Also, train car switching will cause the interruption of networks, effecting passenger information system and intrain WiFi service.

Passenger’s tolerance toward network interruption is limited and this is one of the important factors of customer satisfaction.

Train Ring vs. Existing Solutions

Common Rapid Spanning Tree Protocol (RSTP) and Coupling Ring can be applied to rail train network for redundancy of multiple train cars. However, each solution has its own drawbacks such as longer recovery time or nonautomatic recovery. Lantech provides a new solution called "Train Ring", which can automatically recover the network within 50ms without reconfigure the settings!

Lantech Train Ring is evolved from traditional Coupling Ring. It eliminates the setting process, and will automatically identify the primary and backup path dynamically, without any configuration required.

Lantech Train Ring allows train operators to rapidly change composition of trains with high efficiency and flexibility. Since all settings are done automatically, configuration errors and cost can be minimized. The recovery time of Train Ring is less than 50ms, so passengers can hardly recognize the interruption caused by topology change.

For more details, please visit our homepage: 

www.lantechcom.eu

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

ALTANA Division BYK Opens New Site in Shanghai

.
– Specialty chemicals company expanding its presence in Asia through biggest single investment in China so far
– New integrated site to better serve needs of customers locally

ALTANA’s BYK division is expanding its operations in the Shanghai region to meet the anticipated growth in demand in the key Chinese market. The Asia region accounts for one third of sales, and has made a substantial contribution to additives specialist BYK. The new five-hectare site in Shanghai (around 54,000 sq.m.) is home to laboratories, a distribution center, and administration and was constructed in just two years. BYK invested around 38 million euros. Some 100 employees will work here in full operation.

“The new site will significantly enhance our presence in the Chinese market, and will enable us to focus on individual customer solutions in the growing Asian market,” declared Martin Babilas, CEO of ALTANA AG, during the opening ceremony. “The new and ultra-modern facility is embedded in the Shanghai Chemical Industry Park (SCIP) where we enjoy ideal framework conditions for our innovative, differentiated additive solutions.”

“Creating customer value is the core of our strategy at BYK. Optimum technical laboratory support, product innovations, and fast, reliable supply chains play a crucial role in this strategy. Thanks to the facility being opened today, we can offer our Chinese customers more direct services, as well as differentiated products that will provide an additional impetus to our business in the region,” explained Stephan Glander, BYK Division President.

Each year, BYK invests 7 to 8 percent of its revenue in research and development.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

Ravenquest Secures Health Canada Cultivation License at Edmonton Facility

RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “Company” or “RavenQuest” – https://www.commodity-tv.net/c/search_adv/?v=298814) a federally-licensed producer of cannabis, is pleased to announce it has secured a Health Canada License to Cultivate at the Company’s flagship Edmonton facility.  The license allows RavenQuest to begin cannabis production inside the revolutionary Orbital Garden 2.0 grow technology at its ultra-modern Edmonton production facility.  The Edmonton facility increases RavenQuest’s production capacity by 275%, adding 7,000 kg of annual capacity and bringing the Company’s total production capacity to approximately 11,000 kg per year.

George Robinson, CEO of RavenQuest, stated “this is a very exciting time and inflection point for our organization.  This milestone catapults our company toward dramatic cannabis production and revenue increases for 2019.   We have been busy preparing for this pivotal moment.  Our Edmonton team is ready and all equipment is in place, including our Orbital Garden 2.0 technology.  Starting material has been carefully prepared and curated at our Markham facility and will be moved to Edmonton to begin production immediately” Robinson continued.

“Production will be ramped up rapidly and efficiently in order to meet supply agreements with our provincial partner, BCLDB, as well as major bulk buyer, Wayland Group” stated Robinson.  “We have already pre-sold all cannabis production from our Markham and Edmonton facilities for the calendar year of 2019” he continued.

For more information, access RavenQuest’s investor presentation, fact sheet and videos here.

About RavenQuest BioMed Inc.

RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.  RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta.

RavenQuest maintains a research partnership with McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant.  The Company focuses on partnerships with Indigenous communities.

On Behalf of the Board of Directors of
RAVENQUEST BIOMED INC.

"George Robinson"
Chief Executive Officer

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statements

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws, including statements with respect to anticipated production capacity.  The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes.  By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved.  These risks and uncertainties include but are not limited to those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements.  The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox